Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Stocks in this Quantisnow insightHealth Care
Historical context for MBRX
Across the 12 sessions after earlier MBRX headlines, the stock closed higher 5 times and lower 7 times, with a median move of 6.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MBRX | SPY |
|---|---|---|---|
| Jan 13, 2026 | Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects | +5.9% | -0.2% |
| Jan 12, 2026 | Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs | +1.8% | +0.2% |
| Dec 17, 2025 | Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors | -11.7% | -1.1% |
| Dec 10, 2025 | Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds | -27.1% | +0.7% |
| Dec 9, 2025 | Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal "MIRACLE" Phase 3 AML Trial on Pace for Q1 2026 | -8.6% | -0.1% |
| Dec 8, 2025 | Moleculin Announces New Annamycin Collaboration in Brain Tumors | +0.1% | -0.3% |
Keep researching MBRX
- What is Earnings call?A conference call or webcast where company management discusses quarterly results and guidance and takes questions from analysts.
- Earnings season calendarEarnings season starts about two weeks after each quarter ends and runs roughly six weeks. Learn the timing, BMO and AMC releases, whisper numbers and guidance.
- MBRX insider tradesEvery buy and sale reported by Moleculin Biotech Inc. officers, directors and large holders.
- MBRX financial statementsRevenue, profit, cash flow and balance sheet from Moleculin Biotech Inc.'s SEC filings.
- MBRX dividend historyDividends Moleculin Biotech Inc. has declared, with ex-dates and payment dates.
Quantisnow market dataNASDAQ
MBRX
Moleculin Biotech Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for MBRX
Full MBRX profile on Quantisnow Follow MBRX and get a push notification the moment its next story breaks.